Joseph K. Belanoff, CEO: Corcept Therapeutics CORT Planned sale · Filed 25/07/17

Trade details

Type: Planned sale notice
Stock: Corcept Therapeutics CORT
Person: Joseph K. BelanoffCEO
Planned sale date: 25/07/17
Filed: 25/07/17

More to sell after $6.2M in 3 months

Corcept Therapeutics trades, last 26 weeks

What else happened in Corcept Therapeutics around then

Filed or reported within 30 days of the trade day · 25/06/17~25/08/16

Joseph K. Belanoff's recent trades

Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$895.3K
12,837 sh
$895.3K
Filed 06/02
Traded 06/01
Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$892K
12,837 sh
$892K
Filed 06/01
Traded 06/01
Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$2M
40,000 sh
$2M
Filed 05/05
Traded 05/01
Joseph K. BelanoffCEO
Planned sale10b5-1 planCorcept Therapeutics
Planned sale10b5-1 plan
Corcept Therapeutics
CORT
$1.9M
40,000 sh
$1.9M
Filed 05/01
Traded 05/01
Joseph K. BelanoffCEO
Sell10b5-1 planCorcept Therapeutics
Sell10b5-1 plan
Corcept Therapeutics
CORT
$1.3M
26,198 sh
$1.3M
Filed 03/27
Traded 03/25

Joseph K. Belanoff, CEO — plans to sell 40,000 sh of Corcept Therapeutics CORT · $2.9M · around 07/17 · 10b5-1 plan | Whalegun